EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Population-Level Uncoupling of Antimicrobial Usage and Resistance in Community-Onset Escherichia coli Bloodstream Infections

Peter Collignon iD, John J Beggs, Jan M Bell iD, Denise Daley iD, Elizabeth Roughead iD, On Behalf Of The Australian Group On Antimicrobial Resistance

Pathogens · 25.06.2026 · 15 (7) · 670

DOI: 10.3390/pathogens15070670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 25.06.2026. Verfasst von Peter Collignon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Australian National University, Canberra 2601, Australia. Hauptthemen laut MEDLINE: Escherichia coli Infections, Escherichia coli, Community-Acquired Infections, Anti-Bacterial Agents. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Centre for Disease Control.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial resistance (AMR) is widely considered to be driven by antimicrobial consumption through within-host selection. However, whether this mechanism adequately explains population-level patterns of resistance in invasive infections remains uncertain. If antimicrobial use is the dominant determinant, resistance should be highest in demographic groups with the greatest exposure.

Methods

We conducted a retrospective analysis of 44,792 community-onset Escherichia coli bloodstream infection episodes identified through national Australian surveillance data (2013–2024). Resistance prevalence across individual antimicrobials and composite multidrug resistance panels was analysed by age and sex. These data were compared with community antimicrobial dispensing derived from the Pharmaceutical Benefits Scheme. Mean resistance was modelled as a function of age and sex.

Results

Antimicrobial use was substantially higher in females than males (~23% overall) and increased markedly with age, with individuals aged ≥80 years receiving approximately three times more antimicrobials than those aged 25–30 years. In contrast, resistance was consistently lower in females across most antimicrobials and composite measures. Resistance demonstrated an inverted U-shaped age distribution, peaking at 30–40 years before declining in older age groups. From early adulthood to older age, antimicrobial dispensing increased threefold, whereas mean resistance declined by approximately 20%. These patterns were consistent across antimicrobial classes, years, and jurisdictions.

Conclusions

These findings show that demographic patterns of antimicrobial resistance in community-onset E. coli bloodstream infections are not well explained by a simple population-level consumption model. These findings should be interpreted as important hypothesis-generating insights. Although antimicrobial exposure remains important for individual-level selection, the observed discordance between prescribing and resistance suggests that other factors, including differences in transmission pathways, healthcare contact, disease prevalence, community sanitation and socioeconomic circumstances may also significantly shape resistance patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coli InfectionsEscherichia coliCommunity-Acquired InfectionsAnti-Bacterial AgentsDrug Resistance, BacterialBacteremiaDrug Resistance, Multiple, BacterialHumansFemaleMaleRetrospective StudiesAgedAged, 80 and overAustraliaAdultMiddle AgedChild, PreschoolInfantAdolescentChildYoung AdultInfant, Newborn

Stichwörter der Autor:innen

AMRE. coliageantibioticsantimicrobial resistancebloodstream infectionsgendersexsex: elderly

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Medical School, Australian National University, Canberra 2601, Australia.
  • Microbiology, Canberra Hospital, Canberra 2605, Australia.
  • Independent Researcher, Melbourne 3000, Australia.
  • Australian Group on Antimicrobial Resistance (AGAR), Perth 6000, Australia.
  • Microbiology, Fiona Stanley Fremantle Hospitals Group, Murdoch 6961, Australia.
  • College of Health, Adelaide University, Adelaide 5000, Australia.

ORCID-Profile: Peter Collignon, Jan M Bell, Denise Daley, Elizabeth Roughead

Förderung

  • Australian Centre for Disease Control

Zitieren

APA

Collignon, P., Beggs, J. J., Bell, J. M., Daley, D., Roughead, E., & On Behalf Of The Australian Group On Antimicrobial Resistance (2026). Population-Level Uncoupling of Antimicrobial Usage and Resistance in Community-Onset Escherichia coli Bloodstream Infections. Pathogens, 15(7), 670. https://doi.org/10.3390/pathogens15070670

Vancouver

Collignon P, Beggs JJ, Bell JM, Daley D, Roughead E, On Behalf Of The Australian Group On Antimicrobial Resistance. Population-Level Uncoupling of Antimicrobial Usage and Resistance in Community-Onset Escherichia coli Bloodstream Infections. Pathogens. 2026;15(7):670. doi:10.3390/pathogens15070670

BibTeX
@article{Collignon2026,
  author = {Collignon, Peter and Beggs, John J and Bell, Jan M and Daley, Denise and Roughead, Elizabeth and On Behalf Of The Australian Group On Antimicrobial Resistance},
  title = {Population-Level Uncoupling of Antimicrobial Usage and Resistance in Community-Onset Escherichia coli Bloodstream Infections},
  journal = {Pathogens},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {670},
  doi = {10.3390/pathogens15070670}
}
Kostenlos starten →